Amisulpride augmentation in clozapine-unresponsive schizophrenia: A randomised, double-blind, placebo-controlled trial.

Trial Profile

Amisulpride augmentation in clozapine-unresponsive schizophrenia: A randomised, double-blind, placebo-controlled trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 02 Mar 2016

At a glance

  • Drugs Amisulpride (Primary) ; Clozapine
  • Indications Schizophrenia
  • Focus Therapeutic Use
  • Acronyms AMICUS
  • Most Recent Events

    • 31 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
    • 13 Feb 2015 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
    • 23 Jan 2015 Accrual to date is 38% according to United Kingdom Clinical Research Network record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top